Crosspoint Capital Strategies’s Argan AGX Stock Holding History

Crosspoint Capital Strategies’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-120	Closed	-$8K	–	142
2017 Q1	$8K	Hold	120	–	–	0.01%	73
2016 Q4	$8K	Buy	+120	New	+$7.49K	0.01%	69

Other funds holding AGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Crosspoint Capital Strategies's AGX Position: Q2 2017 in Review

Crosspoint Capital Strategies sold out of Argan (AGX) in Q2 2017, closing a stake of 120 shares — an estimated $8K sold.

Crosspoint Capital Strategies first reported a position in AGX in Q4 2016 and held it in 2 quarters. The position peaked at $8K in Q1 2017. 186 funds tracked by Wall St. Rank hold AGX as of Q2 2017.

Crosspoint Capital Strategies reported no remaining Argan position as of Q2 2017 after selling out during the quarter.
Crosspoint Capital Strategies sold 120 Argan shares in Q2 2017, an estimated $8K.
Crosspoint Capital Strategies first reported a position in Argan in Q4 2016 and held it in 2 quarters.
Crosspoint Capital Strategies's Argan position peaked at $8K in Q1 2017.
186 funds tracked by Wall St. Rank held Argan as of Q2 2017.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2017, filed 1 Aug 2017.